ViaLase CEO talks innovations in glaucoma treatment

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

The path to faster visual recovery following glaucoma surgery

Speed the return to baseline visual acuity—and make your patients happy.

Pharmaceutical company files IND application with FDA for glaucoma candidate

TearClear to start clinical trial for TC-002 latanoprost ophthalmic solution 0.005%.

Donald Zack, MD, PhD, honored for vision research

August 10, 2021

The Research to Prevent Blindness (RPB), the Association of University Professors of Ophthalmology (AUPO) and an anonymous donor have recognized Donald Zack, MD, PhD, for ground-breaking contributions to the field of vision research.